about
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is eval...
Read More
83.65
1.66
(2.02%)
637.8K
XNAS Volume
XNAS 03 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Abivax - ADR is on 09 Sep 2025 for the purpose of Abivax SA Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Abivax - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..